Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns
October 27, 2022 08:00 ET
|
Sema4
-- Abnormal findings reported in 63% of infants in study, change in health management recommended in 88% of cases ---- Sema4|GeneDx contributes to latest data in the SeqFirst study being presented at...
Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels
October 26, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, has collaborated on research debunking a commonly held belief that exome and genome sequencing...
$1.2+ Billion Worldwide Direct-To-Consumer Genetic Testing Industry to 2027 - Rising Public Awareness and Consumer Empowerment Will Support Market Growth
October 20, 2022 08:08 ET
|
Research and Markets
Dublin, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Direct-To-Consumer Genetic Testing Market By Test Type, By Technology chips, Targeted Analysis, Whole Genome Sequencing, By Sample, By...
Global Epigenetics Market Report 2022: Development of DNA and RNA Modifying Enzymes & the Launch of Highly Sensitive and Selective Tests and Instruments Bolsters Market
October 12, 2022 08:08 ET
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Sema4|GeneDx To Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening Study
October 05, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced it is a partner in the recently launched GUARDIAN study (Genomic Uniform-screening...
Outlook on the Cell Therapy Global Market to 2028 - Increased Demand for Novel, Better Medicines for Diseases Such as Cancer and CVD Has Resulted in an Increase in General Research Efforts
October 05, 2022 07:08 ET
|
Research and Markets
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market, By Use Type, By Therapy Type, By Product, By Technology & By Region- Forecast and Analysis 2022-2028" report has been...
Global Genomic Biomarker Market Report 2022: Increasing R&D into Genomic Biomarkers Driving Growth
September 22, 2022 05:33 ET
|
Research and Markets
Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Global Genomic Biomarker Market Research and Forecast 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global genomics...
Global Genome Sequencing Market Report 2022: Diagnostic Advances Through Genome Sequencing Driving Growth
September 22, 2022 05:03 ET
|
Research and Markets
Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Global Genome Sequencing Market, By Nucleotide Sequenced (DNA v/s RNA), By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others),...
Worldwide CRISPR Industry to 2028 - by Application, End-user and Region
September 15, 2022 07:53 ET
|
Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Global CRISPR Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global CRISPR market is anticipated to grow at a...
Genomics Global Market to Reach $63.5 Billion in 2026 at a CAGR of 18.2%
September 06, 2022 07:08 ET
|
Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Genomics Global Market Report 2022, By Product Type, By Process, By End User" report has been added to ResearchAndMarkets.com's offering. The global...